Perk Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 8.00 Cr
- Paid Up Capital ₹ 6.38 Cr
- Company Age 43 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.85 M
- Satisfied Charges ₹ 6.36 Cr
- Revenue Growth 208.04%
- Profit Growth 296.18%
- Ebitda 60.53%
- Net Worth 5.48%
- Total Assets 30.42%
About Perk Pharmaceuticals
Perk Pharmaceuticals Limited (PPL) is a leading Public Limited Indian Non-Government Company incorporated in India on 24 August 1981 and has a history of 43 years and six months. Its registered office is in Meerut, Uttar Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 8.00 Cr and a paid-up capital of Rs 6.38 Cr.
The company currently has active open charges totaling ₹3.85 M. The company has closed loans amounting to ₹6.36 Cr, as per Ministry of Corporate Affairs (MCA) records.
Monica Kaile, Ritu Kaile, and Krishna Kaile serve as directors at the Company.
Company Details
- Location
Meerut, Uttar Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
L24231UP1981PLC005400
- Company No.
005400
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
24 Aug 1981
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Listed
- ROC Code
Roc Kanpur
Industry
Pharma
Who are the key members and board of directors at Perk Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Krishna Kaile  | Managing Director | 01-Oct-1993 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Monica Kaile | Director | 21-Oct-2015 | Current |
| Ritu Kaile | Whole-Time Director | 21-Oct-2015 | Current |
Financial Performance of Perk Pharmaceuticals.
Perk Pharmaceuticals Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 208.04% increase. The company also saw a substantial improvement in profitability, with a 296.18% increase in profit. The company's net worth moved up by a moderate rise of 5.48%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Perk Pharmaceuticals?
In 2019, Perk Pharmaceuticals had a promoter holding of 52.30% and a public holding of 47.70%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
Open Charges
₹0.39 Cr
Satisfied Charges
₹6.36 Cr
Charges Breakdown by Lending Institutions
- Union Bank Of India : 0.37 Cr
- Uno Bank Of India : 0.02 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 05 Aug 1987 | Uno Bank Of India | ₹0.18 M | Open |
| 05 Jan 1987 | Union Bank Of India | ₹0.18 M | Open |
| 05 Jan 1987 | Union Bank Of India | ₹3.50 M | Open |
| 10 Jun 1998 | The Pradeshiya Industrial & Investment Corporation Of Ltd. | ₹3.18 Cr | Satisfied |
| 25 May 1998 | The Pracieshiya Industrial & Investment Corporation Of Ltd. | ₹3.18 Cr | Satisfied |
How Many Employees Work at Perk Pharmaceuticals?
Perk Pharmaceuticals has a workforce of 9 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Perk Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Perk Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Perk Pharmaceuticals
Recent activity within the organization
- Annual General Meeting
Perk Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
- Balance Sheet
Perk Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kanpur.
- Director Appointment
Monica Kaile was appointed as a Director was appointed as a Director on 21 Oct 2015 & has been associated with this company since 9 years 4 months .
- Director Appointment
Ritu Kaile was appointed as a Whole-Time Director was appointed as a Whole-Time Director on 21 Oct 2015 & has been associated with this company since 9 years 4 months .
- Charges
A charge registered on 10 Jun 1998 via Charge ID 90267877 with The Pradeshiya Industrial & Investment Corporation Of Ltd. was fully satisfied on 12 Aug 2009.
- Charges
A charge registered on 25 May 1998 via Charge ID 90269168 with The Pracieshiya Industrial & Investment Corporation Of Ltd. was fully satisfied on 12 Aug 2009.
Frequently asked questions
What is the Incorporation or founding date of Perk Pharmaceuticals Limited?
Perk Pharmaceuticals Limited was incorporated on 24 Aug 1981.
What is authorized share capital and paid-up capital of Perk Pharmaceuticals Limited?
The authorized share capital of Perk Pharmaceuticals Limited is ₹ 8.00 Cr and paid-up capital is ₹ 6.38 Cr.
Who are the current board members & directors of Perk Pharmaceuticals Limited?
Currently 3 directors are associated with Perk Pharmaceuticals Limited.
- Monica Kaile
- Ritu Kaile
- Krishna Kaile
What is the registered address of Perk Pharmaceuticals Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Perk Pharmaceuticals Limited is A-7 Industrial Estate Partapur Meerut India, Uttar Pradesh, 250103.
What is the corporate identification number (CIN) and company number of Perk Pharmaceuticals Limited?
The corporate identification number (CIN) of Perk Pharmaceuticals Limited is L24231UP1981PLC005400 and the company number is 005400 as per Ministry of Corporate Affairs (MCA).
What is the official website of Perk Pharmaceuticals Limited?
The Official website of Perk Pharmaceuticals Limited is https://www.perkpharma.com
What has been the recent revenue trend for Perk Pharmaceuticals Limited?
According to the financial reports for the fiscal year 2020, the revenue trend for Perk Pharmaceuticals Limited has risen by 208.04%.
How many employees does Perk Pharmaceuticals Limited currently have?
As Per 2020 financial reports, 9 employees are currently employed by Perk Pharmaceuticals Limited.
What change has been observed in the net worth of Perk Pharmaceuticals Limited, and by what percentage?
The financial reports for the fiscal year 2020 indicates that The net worth of Perk Pharmaceuticals Limited has experienced an upsurge of 5.48%.
What are the total open charges for Perk Pharmaceuticals Limited?
As per the financial statements for fiscal Year 2020, The total open charges for Perk Pharmaceuticals Limited amount to ₹ 3.85 M.
When was the last Balance Sheet of Perk Pharmaceuticals Limited filed with the ROC?
The most recent Balance Sheet for Perk Pharmaceuticals Limited was filed with the ROC on 31 Mar 2024.
People also Viewed
RK
Ramesh KaileManaging DirectorVK
Vikram KaileDirectorDK
Dhiraj KaileManaging Director